Barbe-Richaud, J.-B.; Fattori, A.; Lindner, V.; Schuster, C.; Malouf, G.; Pencreach, E.; Somme, L.
EGFR-Mutant Urothelial Carcinoma Harboring an Ala750_Ile759delinsGlyGly Alteration with a Primary Resistance to Polychemotherapy and a Sensitivity to Osimertinib: A Literature Review on EGFR Alterations and Response to EGFR Tyrosine Kinase Inhibitors in Cancers. J. Clin. Med. 2025, 14, 3129.
https://doi.org/10.3390/jcm14093129
AMA Style
Barbe-Richaud J-B, Fattori A, Lindner V, Schuster C, Malouf G, Pencreach E, Somme L.
EGFR-Mutant Urothelial Carcinoma Harboring an Ala750_Ile759delinsGlyGly Alteration with a Primary Resistance to Polychemotherapy and a Sensitivity to Osimertinib: A Literature Review on EGFR Alterations and Response to EGFR Tyrosine Kinase Inhibitors in Cancers. Journal of Clinical Medicine. 2025; 14(9):3129.
https://doi.org/10.3390/jcm14093129
Chicago/Turabian Style
Barbe-Richaud, Jean-Baptiste, Antonin Fattori, Véronique Lindner, Caroline Schuster, Gabriel Malouf, Erwan Pencreach, and Laura Somme.
2025. "EGFR-Mutant Urothelial Carcinoma Harboring an Ala750_Ile759delinsGlyGly Alteration with a Primary Resistance to Polychemotherapy and a Sensitivity to Osimertinib: A Literature Review on EGFR Alterations and Response to EGFR Tyrosine Kinase Inhibitors in Cancers" Journal of Clinical Medicine 14, no. 9: 3129.
https://doi.org/10.3390/jcm14093129
APA Style
Barbe-Richaud, J.-B., Fattori, A., Lindner, V., Schuster, C., Malouf, G., Pencreach, E., & Somme, L.
(2025). EGFR-Mutant Urothelial Carcinoma Harboring an Ala750_Ile759delinsGlyGly Alteration with a Primary Resistance to Polychemotherapy and a Sensitivity to Osimertinib: A Literature Review on EGFR Alterations and Response to EGFR Tyrosine Kinase Inhibitors in Cancers. Journal of Clinical Medicine, 14(9), 3129.
https://doi.org/10.3390/jcm14093129
